CorEvitas HQ is a clinical research site located in Waltham, Massachusetts, United States 02451.
Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.
CorEvitas HQ has participated in 2 clinical trials.
Therapeutic areas: Geographic Atrophy, Diabetic Macular Edema.
Sponsors: Boehringer Ingelheim.
Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
CorEvitas HQ has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
CorEvitas HQ has 2 clinical trials on record. Their work covers Geographic Atrophy, Diabetic Macular Edema.
CorEvitas HQ has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.